Business news

Coil Assisted Flow Diverters Market is expected to grow at a CAGR of Approximately Over 2022-2030

A brand-new intravascular stent called a coil-assisted flow diverter is intended to be used in conjunction with embolization coils to treat aneurysms. Coil-assisted flow diverters are less constrictive because the coil is maintained independently within the aneurysm sac without the need for parent vessel stabilization. They are made of highly visible braid elastic material.

Coil-assisted flow diverters are offered by Cerus Endovascular under the name Neqstent coil-assisted flow diverters. According to the Brain Aneurysm Foundation, 30,000 brain aneurysms rupture each year and 6 million Americans have unruptured brain aneurysms.

Coil-assisted flow diverters work with embolization coils to stabilize and heal aneurysm sacs through flow diversion. With the aid of high precision re-sheath able placement into the aneurysm sac neck, it also has a mesh braid of contour neurovascular system with memory properties, self-anchoring, stabilizing, and less restricting sizing.

Coronavirus and lockdown have had an impact on the world market for coil-assisted flow diverters by limiting patient access to medical facilities and pharmacies for routine checkups and diagnosis. Although the impact on emergency cardiovascular procedures has been lessened.

Due to the rising incidence of aneurysms, including brain and aortic aneurysms, and developing stent technology, the global coil-assisted flow diverters market is expected to expand profitably. Wide-neck aneurysms and coiling wide-neck aneurysms can be treated with the advanced features of coil-assisted flow diverters, which are otherwise challenging to treat with open brain surgery.

Coil-Assisted Flow Diverters Market: Drivers and RestraintsThe advanced features of coil-assisted flow diverters, which enable access to the incurable wide-neck brain aneurysm, are the main factors driving the global market for these devices, which are well-liked by medical professionals.

The coil-assisted flow diverter market is expanding as a result of ongoing clinical trial success rates and approvals. Coil-assisted flow diverters are dependable for aneurysm closure, effective for anti-platelet therapy, minimally invasive, and safe for thromboembolic complications.

The improved healthcare infrastructure, rising healthcare costs, growing public awareness, and government suppospecializedrt, in addition to hospitals, clinics, and ambulatory surgical centers, have all contributed to the consolidation of the coil-assisted flow diverter market.

However, certain factors, such as periprocedural stroke and deaths associated with procedures or poorly chosen patients, limit the market’s rapid expansion for coil-assisted flow diverters.

For the appropriate use of coil-assisted flow diverters for the treatment of unruptured brain aneurysms, the FDA has issued safety guidelines and recommendations. The market is also being affected by expensive, complex surgical procedures for coil-assisted flow diverters and a lack of qualified workers. Even though the market for coil-assisted flow diverters is expected to expand globally due to its high acceptance, it still needs government backing and further approvals.

Coil-Assisted Flow Diverters Market: OverviewWith its cutting-edge features being accepted by medical professionals and government-friendly policies, the coil market-assisted flow diverters is anticipated to grow profitably.

Due to its flexibility to fit inside the narrow neck of the Wide-neck aneurysm, which is otherwise inaccessible to surgical clippings, wide-neck bifurcation dominates the coil-assisted flow diverters’ applications. With specialized research and treatment facilities, qualified surgeons, and access to coil-assisted flow diverters, hospitals dominate the market for these devices through distribution channels.

Coil-Assisted Flow Diverters Market: Regional OutlookSince the Neqstent coil-assisted flow diverter is already authorized in this region and is actively used to meet the rising demand in the treatment of aneurysm sac and long-term occlusions, Europe currently holds the majority of the global coil market assisted flow diverters.

North America is home to the second-largest coil-assisted flow diverter market, thanks to technological advancements in healthcare infrastructure and key U.S.-based industry players like Cerus Endovascular. The market for coil-assisted flow diverters in the Asia Pacific region is expanding gradually.

The market is anticipated to expand in South Asia, which includes China and India, and East Asia, which includes Japan, due to advancements in healthcare and research, a rising population, and an increase in intracranial diseases.

Although growth in Latin America is predicted to be slower than average, it is anticipated to catch up to the current stent market expansions as research and healthcare standards rise. With their advanced research, healthcare, and awareness, Israel and South Africa are two of the major contributing nations that will help the MEA and Africa coil-assisted flow diverters market to grow at a steady rate.

Coil-Assisted Flow Diverters Market: Key players in the global coil-assisted flow diverters market include

  • Medtronic
  • DePuy Synthes
  • Stryker
  • MicroPort
  • OBEX Medical
  • Abbott
  • Carditis
  • Penumbra Inc. and Balt.

Coil-Assisted Flow Diverters Market: SegmentationThe global coil-assisted flow diverters market is segmented into the types of applications, distribution channels, and regions.


  • Wide-neck bifurcation aneurysms
  • Bifurcation aneurysms

Distribution Channels

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres

For Critical Insights, Request a Sample Copy

To Top

Pin It on Pinterest

Share This